KURT GUSTAFSON
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
STEPHEN ALLEN, STEPHEN L. ALLEN, STEVE ALLEN, STEVE L. ALLEN, JEFF BAXTER, JEFF 10005 MUIRLANDS BLVD., SUITE G BAXTER, JEFF L. BAXTER, STEPHEN BLOCK, STEPHEN A. BLOCK, STEPHEN L. BLOCK, STEVEN BLOCK, STEVEN A. BLOCK, LISA BRATKOVICH, MICHAEL BRAUSER, ANN N. COHEN, REID DABNEY, REID J D DABNEY, HUGH DUNKERLEY, HUGH D P DUNKERLEY, HUGH DUNKERLY, KEVIN FARR, KEVIN L. FARR, KEVIN M. FARR, ROB FRIED, ROBERT FRIED, ROBERT L. FRIED, ROBERT N. FRIED, MARK FRIEDMAN, MARK L. FRIEDMAN, BRIANNA N. GERBER, MARK S. GERMAIN, MARK GERMAINE, KURT L. GUSTAFSON, GLENN L. HALPRYN, JEFFREY HIMMEL, BARRY HONIG, BARRY C. HONIG, FRANK JAKSCH, FRANK L. JAKSCH, FRANK L. JR. JAKSCH, FRANK, JR. JAKSCH, FRANK L. JAKSCH, JR., MEGAN JORDAN, TONY LAU, TONY L. LAU, TSZ HO TONY L. LAU, CURTIS LOCKSHIN, CURTIS A. LOCKSHIN, GARY N. NG, KRISTIN N. PATRICK, TROY RHONEMUS, TROY L. RHONEMUS, MATTHEW ROBERTS, STEVEN RUBIN, STEVEN L. RUBIN, STEVEN N. RUBIN, HAMED N. SHAHBAZI, TROY THONEMUS, THOMAS VARVARO, THOMAS C. VARVARO, THOMAS L. VARVARO, TOM VARVARO, WENDY YU, WENDY L. YU, WENDY N. YU, WING TAK WENDY L. YU
DIRECTOR
ESPER BOEL, BRUCE L.A. CARTER, BASSIL DAHIYAT, BASSIL I. DAHIYAT, JOHN DESJARLAIS, CELIA ECKERT, DOUGLAS M. FAMBROUGH, ELLEN FEIGAL, JONATHAN FLEMING, DONALD C. FOSTER, KEVIN GORMAN, YUJIRO HATA, JOHN KUCH, RICHARD A. LERNER, BEN N.M. MACHIELSE, A. BRUCE MONTGOMERY, TIMOTHY PEARSON, RICHARD RANIERI, DAGMAR ROSA-BJORKESON, ATUL SARAN, JOHN S., III STAFFORD, CHARLES K. STEWART, HAROLD R. WERNER, ALLEN YANG
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731]
DECLINE TO DISCLOSE
Equity
2025-08-26
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-11-12
D
BIOTECHNOLOGY
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833]
DECLINE TO DISCLOSE
Equity
2020-05-07
D
BIOTECHNOLOGY
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833]
DECLINE TO DISCLOSE
Equity
2019-08-15
D
BIOTECHNOLOGY
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833]
DECLINE TO DISCLOSE
Debt
2019-05-17

